Fundraising FoxEpiwatch
Baltimore, US · Founded 2020 · Delaware corporation · 3 known investors
Find your way into Epiwatch
Sign up to see every warm intro you have to Epiwatch
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Epiwatch team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.
Founders & leadership
Epiwatch was founded in 2020 by Nathan Crone and Gregory Krauss.
NC
Nathan CroneCo-founder
GK
Gregory KraussCo-founder
TP
Teresa PregoChief Executive OfficerTeresa Prego is Executive Officer and Director at EpiWatch, an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and alerts users and caregivers in real time. She has background in digital health, medical devices, diagnostics, and healthcare systems.
DP
Dean PapadopoulosNamed on SEC filing
Board
DH
Daniel HanleyBoard director
RS
Richard SchmittBoard director
RT
Richard ThomasBoard director
ME
Michael E. SingerBoard director
RS
Robert SmithBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 8 of 11 rounds · 2021–2026
▶$500KofferedAug 2026 · Other Health CareRule 506(b)
▶$500KofferedAug 2026 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Richard SchmittDirector
- Teresa PregoExecutive Officer, Director
- Robert SmithDirector
- Offering amount
- $500K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$300KofferedJul 2026 · Other Health CareRule 506(b)
▶$300KofferedJul 2026 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Richard SchmittDirector
- Teresa PregoExecutive Officer, Director
- Robert SmithDirector
- Offering amount
- $300K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$750KofferedSep 2025 · Other Health CareRule 506(b)
▶$750KofferedSep 2025 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Teresa PregoExecutive Officer, Director
- Richard ThomasDirector
- Robert SmithDirector
- Richard SchmittDirector
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Daniel HanleyDirector
- Offering amount
- $750K
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$190KraisedOct 2024 · 6 investors · Other Health CareRule 506(b)
▶$190KraisedOct 2024 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard SchmittDirector
- Daniel HanleyDirector
- Robert SmithDirector
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Michael E. SingerDirector
- Richard ThomasDirector
- Teresa PregoExecutive Officer, Director
- Amount sold
- $190K
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$250KraisedJul 2024 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedJul 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel HanleyDirector
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Richard SchmittDirector
- Richard ThomasDirector
- Teresa PregoExecutive Officer, Director
- Michael E. SingerDirector
- Offering amount
- $850K
- Amount sold
- $250K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$300KraisedJan 2024 · 10 investors · Other Health CareRule 506(b)
▶$300KraisedJan 2024 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard SchmittDirector
- Michael E. SingerDirector
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Richard ThomasDirector
- Daniel HanleyDirector
- Offering amount
- $750K
- Amount sold
- $300K
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$55KraisedNov 2023 · 2 investors · Other Health CareRule 506(b)
▶$55KraisedNov 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel HanleyDirector
- Michael E. SingerDirector
- Richard ThomasDirector
- Richard SchmittDirector
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Offering amount
- $400K
- Amount sold
- $55K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$340KraisedJun 2023 · 9 investors · Other Health CareRule 506(b)
▶$340KraisedJun 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard ThomasDirector
- Dean PapadopoulosExecutive Officer, Director, Promoter
- Michael E. SingerDirector
- Daniel HanleyDirector
- Richard SchmittDirector
- Offering amount
- $375K
- Amount sold
- $340K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
EmpaticaEmpatica offers an FDA-cleared health monitoring platform combining medical wearables and digital biomarkers to collect continuous, clinical-quality health data from daily life. It serves researchers, clinicians, and pharmaceutical companies for clinical trials and remote patient monitoring across therapeutic areas including neurology and Parkinson's disease.
AhaThe American Hospital Association's Team Training Program delivers evidence-based TeamSTEPPS training and resources to healthcare professionals to improve team collaboration, patient safety, and workforce well-being. The program serves clinical and nonclinical healthcare teams through tailored training and an online learning community.
Companies working in the same space as Epiwatch.
Frequently asked questions
- What does Epiwatch do?
- EpiWatch is an FDA-cleared seizure detection app for Apple Watch that monitors for tonic-clonic seizures and sends real-time alerts to users and their caregivers. The app is designed for people with epilepsy in the United States to help reduce the risk of sudden unexpected death in epilepsy (SUDEP) and enable faster intervention.
- Who founded Epiwatch?
- Epiwatch was founded by Nathan Crone, Gregory Krauss in 2020.
- Who are Epiwatch's investors?
- Epiwatch's investors include Iaso Ventures, Maryland TEDCO, TEDCO.
- How much funding has Epiwatch raised?
- Epiwatch has disclosed $2.3M raised across 8 of its 11 known rounds.
- Where is Epiwatch headquartered?
- Epiwatch is headquartered in Baltimore, US.